Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. C. Borel, C. Arnaud, D. Monneret, R. Tamisier, P. Roux-Lombard, P. Levy, J. L. Pepin (Grenoble, France; Genève, Switzerland). RANTES is specifically elevated in obesity hypoventilation syndrome. Eur Respir J 2008; 32: Suppl. 52, 3245

Member's Comments

No comment yet.

Related content which might interest you: The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004 The heart in obesity hypoventilation syndrome Source: Eur Respir Monogr 2020; 88: 143-153 Year: 2020 Defining obesity hypoventilation syndrome Source: Breathe, 17 (3) 210089; 10.1183/20734735.0089-2021 Year: 2021 Pleiotropic role of IGF-1 in obesity hypoventilation syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004 Production of TNF-α, MMPs, and MCP-1 by monocytes and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004 Hypoxic challenge assessments in patients with obesity hypoventilation syndrome Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006 The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006 Cardiovascular comorbidity in obesity hypoventilation syndrome: has nocturnal hypoventilation a protective effect? Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017 Obesity hypoventilation syndrome Source: Eur Respir Rev, 28 (151) 180097; 10.1183/16000617.0097-2018 Year: 2019 Relation of serum ghrelin and leptin levels to blood gases disturbance in obesity hypoventilation syndrome patients Source: Annual Congress 2009 - Noninvasive ventilation: new and old aspects Year: 2009 Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007 Does low plasma adiponectin level affect cardiovasculer risk in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Obesity hypoventilation syndrome in childhood Source: Sleep and Breathing Conference 2017 Year: 2017 Nocturnal diaphragm failure in obesity hypoventilation syndrome (OHS) Source: Eur Respir J 2004; 24: Suppl. 48, 115s Year: 2004 Visfatin levels in sleep apnea syndrome Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Treatment strategies in obesity hypoventilation and overlap syndrome Source: Annual Congress 2010 - Challenges in sleep medicine: ventilatory failure during sleep Year: 2010 Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004